These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5565254)

  • 41. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
    Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
    Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH; Gelder MG
    Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevention of recidivism of schizophrenics treated with fluphenazine enanthate.
    del Giudice J; Clark WG; Gocka EF
    Psychosomatics; 1975; 16(1):32-6. PubMed ID: 1178806
    [No Abstract]   [Full Text] [Related]  

  • 44. Fluphenazine hydrochloride, enanthate, and decanoate in the management of chronic psychosis.
    Itil T; Keskiner A
    Dis Nerv Syst; 1970 Sep; 31():Suppl:37-42. PubMed ID: 4920313
    [No Abstract]   [Full Text] [Related]  

  • 45. Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation.
    DeWolfe AS; Barrell RP; London L; Spaner FE
    Psychosomatics; 1971; 12(3):186-90. PubMed ID: 4950862
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.
    Carpenter WT; Buchanan RW; Kirkpatrick B; Lann HD; Breier AF; Summerfelt AT
    Am J Psychiatry; 1999 Mar; 156(3):412-8. PubMed ID: 10080557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depot fluphenazine for schizophrenia.
    Adams CE; Eisenbruch M
    Cochrane Database Syst Rev; 2000; (2):CD000307. PubMed ID: 10796340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia.
    Altamura AC; Mauri MC; Girardi T; Panetta B
    Int J Clin Pharmacol Res; 1990; 10(4):223-8. PubMed ID: 2079381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delayed severe extrapyramidal disturbance following frequent depot phenothiazine administration.
    Warner AM; Wyman SM
    Am J Psychiatry; 1975 Jul; 132(7):743-5. PubMed ID: 1137022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
    Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
    J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intramuscular formulations of fluphenazine and their duration of activity in the rat [proceedings].
    Florence AT; Vezin WR; Ray-Johnson ML; Stevens HN
    J Pharm Pharmacol; 1978 Dec; 30 Suppl():28P. PubMed ID: 32282
    [No Abstract]   [Full Text] [Related]  

  • 52. Fluphenazine decanoate in the treatment of chorea: a double-blind study.
    Terrence CF
    Curr Ther Res Clin Exp; 1976 Aug; 20(2):177-83. PubMed ID: 133787
    [No Abstract]   [Full Text] [Related]  

  • 53. [Prolonged treatment of schizophrenic psychoses with depot-fluphenazine ("lyogen decanoate")].
    Bohacek N; Mihovilović M
    Neuropsihijatrija; 1968; 16(3):69-73. PubMed ID: 5195835
    [No Abstract]   [Full Text] [Related]  

  • 54. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparative study of fluphenazine ethanate, fluphenazine bichlorhydrate and placebos in chronic schizophrenics].
    Tetreault L; Bordeleau JM; Albert JM; Rajotte P
    Can Psychiatr Assoc J; 1969 Apr; 14(2):191-8. PubMed ID: 4891134
    [No Abstract]   [Full Text] [Related]  

  • 56. behavior of rats and mice administered active metabolites of fluphenazine, 7-hydroxy-fluphenazine and fluphenazine-sulfoxide.
    Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):76-85. PubMed ID: 7194019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH; Gelder MG
    Br J Clin Pharmacol; 1979 Dec; 8(6):565-70. PubMed ID: 533577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A clinical evaluation of fluphenazine enanthate.
    Goldberg HL; DiMascio A; Chaudhary B
    Dis Nerv Syst; 1970 Sep; 31():Suppl:46-7. PubMed ID: 5476358
    [No Abstract]   [Full Text] [Related]  

  • 59. [Long-term therapy with depot-fluphenazine Dapotum in schizophrenia].
    Moldenhauer B
    Med Welt; 1966 Jul; 27():1477-81. PubMed ID: 5985539
    [No Abstract]   [Full Text] [Related]  

  • 60. Fluphenazine enanthate and fluphenazine decanoate: a comparative study in chronic schizophrenic outpatients.
    Keskiner A; Itil TM; Holden JM
    Psychosomatics; 1969; 10(1):42-5. PubMed ID: 5780681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.